Lead author Dr Sigrid Breit, from the University of Bern, said: GLP-1 RAs [receptor agonists] may have antidepressant and anti-anxiety effects, potentially due to their anti-inflammatory and anti-oxidative properties, which can also help reduce neuroinflammation. These results are particularly important for people with severe mental disorders, who are three times more likely to be living with obesity than the general population. Mental health experts welcomed the findings
Week 16 feels effortless even though weight loss rate has slowed
The first is to simply change the time of day that you take your thyroid medication
Conversely, insulin insensitivity may disrupt dopaminergic signalling and motivation
were struggling to stock some of the newest weight-loss medications
A recent study estimated the lifetime benefits of combination therapy with an SGLT2i, GLP-1RA, and ns-MRA in patients with T2D and albuminuria